or
forgot password

    • cancer clinical trials in ypsilanti, MI

    • Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer
    ImClone Investigational Site
    Ypsilanti, Michigan 48198
    Breast Cancer
    Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes
    ImClone Investigational Site
    Ypsilanti, Michigan 48198
    Cancer, Solid Tumor
    Decision Aid to Technologically Enhance Shared Decision Making
    University of Michigan Family Medicine at Corner Health Center
    Ypsilanti, Michigan 48197
    Colorectal Cancer
    A Study of Ramucirumab and Paclitaxel in Patients With Solid Tumors
    ImClone Investigational Site
    Ypsilanti, Michigan 48198
    Malignant Solid Tumor
    A Study of Ramucirumab and Docetaxel in Patients With Solid Tumors
    ImClone Investigational Site
    Ypsilanti, Michigan 48198
    Malignant Solid Tumor
    A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer
    ImClone Investigational Site
    Ypsilanti, Michigan 48198
    Colorectal Neoplasms
    Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy
    ImClone Investigational Site
    Ypsilanti, Michigan 48198
    Colorectal Neoplasms, Metastases, Neoplasm
    Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
    ImClone Investigational Site
    Ypsilanti, Michigan 48198
    Non-small Cell Lung Cancer
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Michigan Heart, P.C.
    Ypsilanti, Michigan 48197
    Atrial Fibrillation, Atrial Flutter
    Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
    Respiratory Medicine Research Institute of Michigan, PLC
    Ypsilanti, Michigan 48197
    Hereditary Angioedema
    Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)
    Respiratory Medicine Research Institute of Michigan, PLC
    Ypsilanti, Michigan 48197
    Hereditary Angioedema
    The Fruit and Vegetable Study
    Ypsilanti Family Health Center
    Ypsilanti, Michigan 48197
    Cancer
    A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma
    ImClone Investigational Site
    Ypsilanti, Michigan 48198
    Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET), Rhabdomyosarcoma, Leiomyosarcoma, Adipocytic Sarcoma, Synovial Sarcoma
    A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer
    ImClone Investigational Site
    Ypsilanti, Michigan 48198
    Prostate Cancer
    Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy
    ImClone Investigational Site
    Ypsilanti, Michigan 48198
    Advanced Solid Tumors
    A Study of IMC-A12 in Patients With Tumors Who No Longer Respond to Treatment or Who No Treatment if Available
    ImClone Investigational Site
    Ypsilanti, Michigan 48198
    Advanced Solid Tumors
    Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
    Huron Gastroenterology Associates
    Ypsilanti, Michigan 48197
    Crohn's Disease